Heidi Hagen

Insider Reports History

Location
Aastrom Biosciences, Inc., 24 Frank Lloyd Wright Drive, Ann Arbor, MI
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Heidi Hagen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heidi Hagen:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vericel Corp Director Common Stock 31.9K $1.42M $44.62 Apr 30, 2025 Direct
Vericel Corp Director Restricted Stock Unit 3.2K $57.6K $18.00 May 1, 2024 Direct
ZIOPHARM ONCOLOGY INC Director Common Stock 146K $20.5K $0.14 Sep 2, 2021 Direct
Vericel Corp Director Stock Option (Right to Buy) 8K Apr 30, 2025 Direct
Vericel Corp Director Restricted Stock Unit 3.2K Apr 30, 2025 Direct

Insider Reports Filed by Heidi Hagen

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VCEL Vericel Corp Apr 30, 2025 4 $0 4 May 2, 2025 Director
VCEL Vericel Corp Mar 3, 2025 3 -$412K 4 Mar 5, 2025 Director
VCEL Vericel Corp Oct 17, 2024 4 $37.4K 4 Oct 21, 2024 Director
VCEL Vericel Corp May 1, 2024 4 $0 4 May 3, 2024 Director
VCEL Vericel Corp May 3, 2023 2 $0 4 May 5, 2023 Director
VCEL Vericel Corp Apr 27, 2023 2 $0 4 Apr 28, 2023 Director
VCEL Vericel Corp Apr 27, 2022 4 $0 4 Apr 29, 2022 Director
TCRT ZIOPHARM ONCOLOGY INC Sep 2, 2021 1 $41.8K 4 Sep 3, 2021 Director
VCEL Vericel Corp May 19, 2021 6 $34.9K 4 May 20, 2021 Director